Bloomage Biotechnology Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
4,444
- Stock Symbol
-
688363
- Investments
-
9
- Share Price
-
$7.08
- (As of Wednesday Closing)
Bloomage Biotechnology General Information
Description
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Contact Information
Website
www.biohyalux.comCorporate Office
- Tower D, Bloomage International Center
- Floor 33, 6A, Jianguomenwai Avenue
- Beijing
- China
Corporate Office
- Tower D, Bloomage International Center
- Floor 33, 6A, Jianguomenwai Avenue
- Beijing
- China
Bloomage Biotechnology Stock Performance
As of 18-Jun-2025, Bloomage Biotechnology’s stock price is $7.08. Its current market cap is $3.41B with 482M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.08 | $7.27 | $5.84 - $12.05 | $3.41B | 482M | 3.52M |
Bloomage Biotechnology Financials Summary
As of 31-Mar-2025, Bloomage Biotechnology has a trailing 12-month revenue of $706M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 3,177,609 | 3,338,496 | 4,404,626 | 9,135,077 |
| Revenue | 706,184 | 748,491 | 858,802 | 944,265 |
| EBITDA | 6,410 | 70,861 | 132,674 | 196,853 |
| Net Income | 4,551 | 24,287 | 83,755 | 144,170 |
| Total Assets | 1,175,327 | 1,185,837 | 1,194,877 | 1,258,353 |
| Total Debt | 56,505 | 49,272 | 29,357 | 56,497 |
Bloomage Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bloomage Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Bloomage Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Bloomage Biotechnology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bloomage Biotechnology Investments & Acquisitions (9)
Bloomage Biotechnology’s most recent deal was a Later Stage VC with SHINEHIGH INNOVATION for . The deal was made on 01-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SHINEHIGH INNOVATION | 01-Apr-2025 | Later Stage VC | Biotechnology | ||
| Hefei HRG Longyan Intelligent Equipment | 26-Oct-2022 | Later Stage VC | Paper Containers and Packaging | ||
| Yek (Beijing) | 19-Jul-2022 | Merger/Acquisition | Personal Products | ||
| Peptites Biotech | 29-Jun-2022 | Later Stage VC | Biotechnology | ||
| Revitacare | 08-Jan-2017 | Merger/Acquisition | Other Devices and Supplies |
Bloomage Biotechnology ESG
Risk Overview
Risk Rating
Updated May, 20, 2025
31.36 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 81
Rank
Percentile
Bloomage Biotechnology Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Revitacare | Paris, France | 2003 | |
| Yek (Beijing) | Beijing, China | 1997 |
Bloomage Biotechnology FAQs
-
When was Bloomage Biotechnology founded?
Bloomage Biotechnology was founded in 2006.
-
Where is Bloomage Biotechnology headquartered?
Bloomage Biotechnology is headquartered in Beijing, China.
-
What is the size of Bloomage Biotechnology?
Bloomage Biotechnology has 4,444 total employees.
-
What industry is Bloomage Biotechnology in?
Bloomage Biotechnology’s primary industry is Biotechnology.
-
Is Bloomage Biotechnology a private or public company?
Bloomage Biotechnology is a Public company.
-
What is Bloomage Biotechnology’s stock symbol?
The ticker symbol for Bloomage Biotechnology is 688363.
-
What is the current stock price of Bloomage Biotechnology?
As of 18-Jun-2025 the stock price of Bloomage Biotechnology is $7.08.
-
What is the current market cap of Bloomage Biotechnology?
The current market capitalization of Bloomage Biotechnology is $3.41B.
-
What is Bloomage Biotechnology’s current revenue?
The trailing twelve month revenue for Bloomage Biotechnology is $706M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
